Stimcell Energetics (STME) EBITDA Margin (2016 - 2023)
Stimcell Energetics (STME) posted quarterly EBITDA Margin of 87531.08% for Q2 2023, down 7454827.0% year-over-year from N/an in Q2 2022, and down 83.61% quarter-over-quarter from 47672.07% in Q1 2023.
Stimcell Energetics (STME) EBITDA Margin (2016 - 2023) Analysis & Trends
Stimcell Energetics' EBITDA Margin history runs 7 years deep, the most recent figure standing at 87531.08% for Q2 2023.
- In Q2 2023, EBITDA Margin fell 7454827.0% year-over-year to 87531.08%; the TTM figure through Feb 2024 stood at 292113.51% (down 27249382.0% YoY), while the FY2023 annual figure was 16207.75%, up 1193188.0% from the prior year.
- EBITDA Margin for Q2 2023 stood at 87531.08%, down from 47672.07% in the prior quarter.
- The five-year high for EBITDA Margin was 322.97% in Q2 2020, with the low at 87531.08% in Q2 2023.
- The 5-year median for EBITDA Margin is 13129.31% (2022), against an average of 19290.5%.
- The sharpest annual moves came in 2021 and 2023: EBITDA Margin jumped 254179 bps in 2021, then plunged 7454827 bps in 2023.
- Stimcell Energetics' EBITDA Margin stood at 2927.66% in 2019, then sank by 231 bps to 9698.4% in 2020, then fell by 5 bps to 10205.57% in 2021, then slumped by 59 bps to 16262.19% in 2022, then sank by 438 bps to 87531.08% in 2023.
- Business Quant data shows STME's EBITDA Margin at 87531.08% in Q2 2023, 47672.07% in Q1 2023, and 16262.19% in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 19.15% |
| 10 | Stimcell Energetics | 4.65 Mn | 4.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2023 | -87,531.08% |
| Feb 28, 2023 | -47,672.07% |
| Nov 30, 2022 | -16,262.19% |
| Aug 31, 2022 | -28,101.55% |
| May 31, 2022 | -12,982.81% |
| Feb 28, 2022 | -26,691.94% |
| Nov 30, 2021 | -10,205.57% |
| Aug 31, 2021 | -19,583.29% |
| May 31, 2021 | -13,395.73% |
| Feb 28, 2021 | -8,140.57% |
| Nov 30, 2020 | -9,698.40% |
| Aug 31, 2020 | -13,275.80% |
| May 31, 2020 | -322.97% |
| Feb 29, 2020 | -10,682.35% |
| Nov 30, 2019 | -2,927.66% |
| Aug 31, 2019 | -1,174.01% |
| Feb 28, 2017 | -56,944.77% |
| Nov 30, 2016 | -71,928.27% |
| Aug 31, 2016 | -4,790.74% |
| May 31, 2016 | -1,116.97% |